Argent BioPharma Ltd. Placing to Raise US$4,500,000
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Argent BioPharma Ltd (RGT)
Argent BioPharma Ltd stock price live, this page displays ASX RGT stock exchange data. View the RGT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Argent BioPharma Ltd real time stock price chart below.
What Is the Argent BioPharma Ltd Stock Price Today?
The Argent BioPharma Ltd stock price today is 0.087.
What Is the Stock Symbol for Argent BioPharma Ltd?
The stock symbol for Argent BioPharma Ltd is ""RGT.""
What Stock Exchange Does Argent BioPharma Ltd Trade On?
Argent BioPharma Ltd is listed and trades on the Sydney stock exchange.
Is Argent BioPharma Ltd a Good Stock to Buy?
Determining whether Argent BioPharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RGT quote. (ISIN: AU0000326647)
What Is the Argent BioPharma Ltd Stock Price Today?
The Argent BioPharma Ltd stock price today is 0.087.
What Is the Stock Symbol for Argent BioPharma Ltd?
The stock symbol for Argent BioPharma Ltd is ""RGT.""
What Stock Exchange Does Argent BioPharma Ltd Trade On?
Argent BioPharma Ltd is listed and trades on the Sydney stock exchange.
Is Argent BioPharma Ltd a Good Stock to Buy?
Determining whether Argent BioPharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RGT quote. (ISIN: AU0000326647)
0.087
+0.006(+7.41%)
Closed·
Fair Value
An estimate of a Argent BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.081
0.095
52 wk Range
0.068
0.440
RGT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Argent BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0810.095
52 wk Range
0.0680.440
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
RGT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Argent BioPharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
May have trouble making interest payments on debt
Argent BioPharma Ltd Company Profile
Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company’s principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the symptomatic relief of Dementia and Alzheimer’s. It is also involved in the preclinical development of Irnican for the treatment of Glioblastoma Multiforme; and R&D, which focuses on wound treatment. The company has collaborated with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care. The company was formerly known as MGC Pharmaceuticals Limited and changed its name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
Compare RGT to Peers and Sector
Metrics to compare | RGT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRGTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −5.0x | −0.7x | |
PEG Ratio | −0.01 | −0.05 | 0.00 | |
Price/Book | −0.7x | 3.6x | 2.6x | |
Price / LTM Sales | 34.9x | 13.8x | 3.4x | |
Upside (Analyst Target) | - | 195.7% | 37.8% | |
Fair Value Upside | Unlock | 10.0% | 5.5% | Unlock |
Earnings
Latest Release
Sep 30, 2025
EPS / Forecast
-0.09 / --
Revenue / Forecast
176.28K / --
People Also Watch
FAQ
What Stock Exchange Does Argent BioPharma Trade On?
Argent BioPharma is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Argent BioPharma?
The stock symbol for Argent BioPharma is "RGT."
What Is the Argent BioPharma Market Cap?
As of today, Argent BioPharma market cap is 6.77M.
What Is Argent BioPharma's Earnings Per Share (TTM)?
The Argent BioPharma EPS (TTM) is -0.31.
When Is the Next Argent BioPharma Earnings Date?
Argent BioPharma will release its next earnings report on 02 Dec 2025.
From a Technical Analysis Perspective, Is RGT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Argent BioPharma Stock Split?
Argent BioPharma has split 5 times.
How Many Employees Does Argent BioPharma Have?
Argent BioPharma has 0 employees.
What is the current trading status of Argent BioPharma (RGT)?
As of 14 Oct 2025, Argent BioPharma (RGT) is trading at a price of 0.087, with a previous close of 0.08. The stock has fluctuated within a day range of 0.081 to 0.095, while its 52-week range spans from 0.068 to 0.440.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.